Jaguar Health hosts symposium on management of diarrhea related to cancer treatment
Napo Pharmaceuticals, a subsidiary of Jaguar Health on target trial adding international sites, targeting enrollment completion in Q2 2023 SAN FRANCISCO, CA/ACCESSWIRE/November 21, 2022/ Jaguar Health, Inc. (NASDAQ: JAGX) and its wholly-owned subsidiary Napo Pharmaceuticals (Napo) announced today that Napo is hosting a hybrid symposium on November 18, 2022 titled Management of diarrhea associated with …
Jaguar Health hosts symposium on management of diarrhea related to cancer treatment Read More »